DUBLIN–(BUSINESS WIRE)–The “Global Acute Cholecystitis Market, By Type, By Cause (Gall Bladder Stones, Tumor, Bile Duct Blockage, Microbial Infection, Others) By Diagnostic Procedure, By Treatment, By End User, By Region, Competition Forecast and Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering.
Global acute cholecystitis market is projected to accomplish an extraordinary growth in the forecast period, 2023-2027 with an impressive CAGR. The market growth can be attributed to the rising instances of gall bladder stone issues. The population is now more concerned and aware of the condition and demanding efficient and effective treatment for the same thereby aiding to the growth of the global acute cholecystitis market in the upcoming five years.
Moreover, rapidly increasing research and advancement in the pharmaceutical department that has effective drugs in the pipeline of market launch is further enunciating the growth factors of the global acute cholecystitis market in the next five years. Increasing geriatric population and their tendency of weaker health and poor health conditions are further aiding the growth of the market in the near future.
Health insurance, governmental schemes have made it more feasible for the patients to afford the treatments and thus supporting the growth of the market. The market may experience a mild restraint due to health conscious consumers that have now changed food habits and are rejuvenating their bodies with healthier food.
Report Scope:
In this report, global Acute Cholecystitis market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Global Acute Cholecystitis Market, By Type:
Calculous Acute Cholecystitis
Acalculous Acute Cholecystitis
Global Acute Cholecystitis Market, By Cause:
Gall Bladder Stones
Tumor
Bile Duct Blockage
Microbial Infection
Others
Global Acute Cholecystitis Market, By Diagnostic Procedure:
Ultrasonography
Cholescintigraphy
CT Scan
ERCP (Endoscopic Retrograde Cholangiopancreatography)
Others
Global Acute Cholecystitis Market, By Treatment:
Surgical
Non-Surgical
Global Acute Cholecystitis Market, By End User:
Hospitals & Clinics
Ambulatory Surgical Centers
Others
Global Acute Cholecystitis Market, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Sweden
Asia-Pacific
China
Japan
India
South Korea
Australia
Thailand
Bangladesh
Middle East & Africa
South Africa
Saudi Arabia
UAE
Turkey
South America
Brazil
Argentina
Colombia
Chile
Key Topics Covered:
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Acute Cholecystitis Treatment Market
4. Executive Summary
5. Voice of Customer
6. Global Acute Cholecystitis Treatment Market Outlook
7. North America Acute Cholecystitis Treatment Market Outlook
8. Europe Acute Cholecystitis Treatment Market Outlook
9. Asia-Pacific Acute Cholecystitis Treatment Market Outlook
10. South America Acute Cholecystitis Treatment Market Outlook
11. Middle East and Africa Acute Cholecystitis Treatment Market Outlook
12. Market Dynamics
13. Market Trends & Developments
14. Competitive Landscape
15. Strategic Recommendations
Companies Mentioned
Boston Scientific Corporation
Fresenius Kabi AG
Pfizer Inc
Teva Pharmaceutical Industries Ltd.
Glenmark Pharmaceuticals Limited
Merck & Co., Inc.
Becton, Dickinson and Company
Simulab Corporation
AbbVie, Inc.
Fortimedix Surgical BV
For more information about this report visit https://www.researchandmarkets.com/r/tr57g3
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
